Avita Medical reports warrant exercises by Perceptive and OrbiMed investors

Avita Medical, Inc. (NASDAQ:RCEL) announced that two investors, Perceptive Credit Holdings V, LP and OrbiMed Royalty & Credit Opportunities IV, LP, have exercised their respective warrants for common stock. Perceptive exercised a warrant issued on June 5, 2026, tied to a credit agreement dated January 13, 2026, allowing for the purchase of up to 150,000 shares after Avita Medical borrowed funds on November 3.

OrbiMed exercised a warrant issued on October 18, 2023, associated with a previous credit agreement, for up to 409,661 shares. Both warrant exercises were conducted through a cashless process, with Avita Medical withholding shares to cover the exercise price and issuing the remaining shares to the investors. The warrant exercises come as Avita Medical's stock has surged 370% year-to-date, trading at $15.63 with a market capitalization of $484 million.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.